Compare · ABT vs CAH
ABT vs CAH
Side-by-side comparison of Abbott Laboratories (ABT) and Cardinal Health Inc. (CAH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. ABT focuses on Biotechnology: Pharmaceutical Preparations, while CAH focuses on Other Pharmaceuticals.
- ABT is the larger of the two at $186.55B, about 3.4x CAH ($55.37B).
- Over the past year, ABT is down 18.0% and CAH is up 49.7% - CAH leads by 67.7 points.
- CAH has been more active in the news (10 items in the past 4 weeks vs 2 for ABT).
- Both have 25 recent analyst ratings on file.
- Company
- Abbott Laboratories
- Cardinal Health Inc.
- Price
- $107.81-0.13%
- $236.40-0.51%
- Market cap
- $186.55B
- $55.37B
- 1M return
- +14.28%
- +1.16%
- 1Y return
- -17.98%
- +49.73%
- Industry
- Biotechnology: Pharmaceutical Preparations
- Other Pharmaceuticals
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 2
- 10
- Recent ratings
- 25
- 25
Abbott Laboratories
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.
Cardinal Health Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Latest ABT
- SEC Form 10-Q filed by Abbott Laboratories
- FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
- Abbott Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
- SEC Form 4 filed by Director Stratton John G
- SEC Form 4 filed by Director Roman Michael F
- SEC Form 4 filed by Director Gonzalez Patricia Paola
- SEC Form 4 filed by Director Conroy Kevin T
- SEC Form 4 filed by Director Ahuja Nita
- EXECUTIVE VICE PRESIDENT Morrone Louis H. covered exercise/tax liability with 269 units of Common shares without par value, decreasing direct ownership by 0.35% to 76,574 units (SEC Form 4)
Latest CAH
- Chief Executive Officer Hollar Jason M. was granted 187,965 shares, increasing direct ownership by 94% to 387,965 units (SEC Form 4)
- Chief Information Officer Greene Michelle D. was granted 17,230 shares, increasing direct ownership by 141% to 29,460 units (SEC Form 4)
- Chief Financial Officer Alt Aaron E was granted 58,738 shares, increasing direct ownership by 222% to 85,146 units (SEC Form 4)
- CEO, PSS Segment Weitzman Deborah was granted 54,823 shares, increasing direct ownership by 104% to 107,700 units (SEC Form 4)
- CEO, GMPD Segment Mason Stephen M was granted 46,992 shares, increasing direct ownership by 184% to 72,482 units (SEC Form 4)
- Chief Legal/Compliance Officer Mayer Jessica L was granted 46,992 shares, increasing direct ownership by 136% to 81,419 units (SEC Form 4)
- Chief Accounting Officer Scherer Mary C. was granted 2,610 shares, increasing direct ownership by 75% to 6,105 units (SEC Form 4)
- Chief Human Resources Officer Pitteroff Valerie Christine was granted 2,610 shares, increasing direct ownership by 33% to 10,632 units (SEC Form 4)
- Cardinal Health Inc. filed SEC Form 8-K: Leadership Update
- Cardinal Health expands home care business with two tuck-in acquisitions